DIVA Laboratories Ltd (4153) — Capital Reinvestment Ratio
Latest as of December 2025:
0.04x
DIVA Laboratories Ltd (4153) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$5.57 Million) in capital expenditures (NT$241.00K). See free cash flow generation of DIVA Laboratories Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
NT$5.57 Million
TWD
Capital Expenditures
NT$241.00K
TWD
Data as of
Dec 2025
Most recent filing
DIVA Laboratories Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks DIVA Laboratories Ltd's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for DIVA Laboratories Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for DIVA Laboratories Ltd from 2017 to 2025. For live market cap and broader valuation context, see market value of DIVA Laboratories Ltd.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | NT$20.77 Million | NT$1.00 Million | ▲ +178.2% |
| 2024 | 0.02x | NT$123.14 Million | NT$2.13 Million | ▼ -43.1% |
| 2023 | 0.03x | NT$252.91 Million | NT$7.69 Million | ▼ -80.5% |
| 2022 | 0.16x | NT$73.19 Million | NT$11.42 Million | ▼ -35.8% |
| 2019 | 0.24x | NT$52.66 Million | NT$12.79 Million | ▼ -3.8% |
| 2018 | 0.25x | NT$86.02 Million | NT$21.71 Million | ▼ -21.4% |
| 2017 | 0.32x | NT$41.45 Million | NT$13.31 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow